Vontobel Holding Ltd. Passage Bio, Inc. Transaction History

Vontobel Holding Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 03, 2024	BUY	$0.96 - $1.88 $76,800 - $150,400	80,000 New	80,000 $76,000
Q1 2023 Apr 12, 2023	BUY	$0.96 - $1.88 $43,200 - $84,600	45,000 Added 128.57%	80,000 $76,000
Q4 2021 Feb 14, 2022	BUY	$6.24 - $10.2 $31,200 - $51,000	5,000 Added 16.67%	35,000 $222,000
Q1 2021 May 11, 2021	BUY	$16.24 - $29.83 $162,399 - $298,300	10,000 Added 50.0%	30,000 $524,000
Q4 2020 Feb 12, 2021	BUY	$14.28 - $29.73 $285,600 - $594,600	20,000 New	20,000 $511,000

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

Stay updated on Vontobel Holding Ltd. with notifications on news.